United States Serum (Blood) Market Report 2017

November 2017 | 109 pages | ID: U4975552A67EN
QYResearch

Abstracts

In this report, the United States Serum (Blood) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Serum (Blood) in these regions, from 2012 to 2022 (forecast).

United States Serum (Blood) market competition by top manufacturers/players, with Serum (Blood) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Thermo Fisher (Life-Tech)
• Sigma-Aldrich
• Merck
• Corning
• Bovogen
• Moregate Biotech
• Biowest
• Gemini
• Bioind
• Tissue Culture Biologicals
• Animal Technologies
• South Pacific Sera
• Lanzhou Minhai
• Changchun Xinuo
• Wuhan Sanli

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Bovine Serum
• FBS

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Biological Products
• Research

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Serum (Blood) Market Report 2017

1 SERUM (BLOOD) OVERVIEW

1.1 Product Overview and Scope of Serum (Blood)
1.2 Classification of Serum (Blood) by Product Category
  1.2.1 United States Serum (Blood) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Serum (Blood) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Bovine Serum
  1.2.4 FBS
1.3 United States Serum (Blood) Market by Application/End Users
  1.3.1 United States Serum (Blood) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Biological Products
  1.3.3 Research
1.4 United States Serum (Blood) Market by Region
  1.4.1 United States Serum (Blood) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Serum (Blood) Status and Prospect (2012-2022)
  1.4.3 Southwest Serum (Blood) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Serum (Blood) Status and Prospect (2012-2022)
  1.4.5 New England Serum (Blood) Status and Prospect (2012-2022)
  1.4.6 The South Serum (Blood) Status and Prospect (2012-2022)
  1.4.7 The Midwest Serum (Blood) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Serum (Blood) (2012-2022)
  1.5.1 United States Serum (Blood) Sales and Growth Rate (2012-2022)
  1.5.2 United States Serum (Blood) Revenue and Growth Rate (2012-2022)

2 UNITED STATES SERUM (BLOOD) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Serum (Blood) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Serum (Blood) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Serum (Blood) Average Price by Players/Suppliers (2012-2017)
2.4 United States Serum (Blood) Market Competitive Situation and Trends
  2.4.1 United States Serum (Blood) Market Concentration Rate
  2.4.2 United States Serum (Blood) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Serum (Blood) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SERUM (BLOOD) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Serum (Blood) Sales and Market Share by Region (2012-2017)
3.2 United States Serum (Blood) Revenue and Market Share by Region (2012-2017)
3.3 United States Serum (Blood) Price by Region (2012-2017)

4 UNITED STATES SERUM (BLOOD) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Serum (Blood) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Serum (Blood) Revenue and Market Share by Type (2012-2017)
4.3 United States Serum (Blood) Price by Type (2012-2017)
4.4 United States Serum (Blood) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SERUM (BLOOD) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Serum (Blood) Sales and Market Share by Application (2012-2017)
5.2 United States Serum (Blood) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SERUM (BLOOD) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Thermo Fisher (Life-Tech)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Serum (Blood) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Thermo Fisher (Life-Tech) Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sigma-Aldrich
  6.2.2 Serum (Blood) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sigma-Aldrich Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Serum (Blood) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Corning
  6.4.2 Serum (Blood) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Corning Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bovogen
  6.5.2 Serum (Blood) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bovogen Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Moregate Biotech
  6.6.2 Serum (Blood) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Moregate Biotech Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biowest
  6.7.2 Serum (Blood) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biowest Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Gemini
  6.8.2 Serum (Blood) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Gemini Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bioind
  6.9.2 Serum (Blood) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bioind Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Tissue Culture Biologicals
  6.10.2 Serum (Blood) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Tissue Culture Biologicals Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Animal Technologies
6.12 South Pacific Sera
6.13 Lanzhou Minhai
6.14 Changchun Xinuo
6.15 Wuhan Sanli

7 SERUM (BLOOD) MANUFACTURING COST ANALYSIS

7.1 Serum (Blood) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Serum (Blood)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Serum (Blood) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Serum (Blood) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SERUM (BLOOD) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Serum (Blood) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Serum (Blood) Sales Volume Forecast by Type (2017-2022)
11.3 United States Serum (Blood) Sales Volume Forecast by Application (2017-2022)
11.4 United States Serum (Blood) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Serum (Blood)
Figure United States Serum (Blood) Market Size (K Units) by Type (2012-2022)
Figure United States Serum (Blood) Sales Volume Market Share by Type (Product Category) in 2016
Figure Bovine Serum Product Picture
Figure FBS Product Picture
Figure United States Serum (Blood) Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Serum (Blood) by Application in 2016
Figure Biological Products Examples
Table Key Downstream Customer in Biological Products
Figure Research Examples
Table Key Downstream Customer in Research
Figure United States Serum (Blood) Market Size (Million USD) by Region (2012-2022)
Figure The West Serum (Blood) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Serum (Blood) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Serum (Blood) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Serum (Blood) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Serum (Blood) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Serum (Blood) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Serum (Blood) Sales (K Units) and Growth Rate (2012-2022)
Figure United States Serum (Blood) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Serum (Blood) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Serum (Blood) Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Serum (Blood) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Serum (Blood) Sales Share by Players/Suppliers
Figure 2017 United States Serum (Blood) Sales Share by Players/Suppliers
Figure United States Serum (Blood) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Serum (Blood) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Serum (Blood) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Serum (Blood) Revenue Share by Players/Suppliers
Figure 2017 United States Serum (Blood) Revenue Share by Players/Suppliers
Table United States Market Serum (Blood) Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Serum (Blood) Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Serum (Blood) Market Share of Top 3 Players/Suppliers
Figure United States Serum (Blood) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Serum (Blood) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Serum (Blood) Product Category
Table United States Serum (Blood) Sales (K Units) by Region (2012-2017)
Table United States Serum (Blood) Sales Share by Region (2012-2017)
Figure United States Serum (Blood) Sales Share by Region (2012-2017)
Figure United States Serum (Blood) Sales Market Share by Region in 2016
Table United States Serum (Blood) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Serum (Blood) Revenue Share by Region (2012-2017)
Figure United States Serum (Blood) Revenue Market Share by Region (2012-2017)
Figure United States Serum (Blood) Revenue Market Share by Region in 2016
Table United States Serum (Blood) Price (USD/Unit) by Region (2012-2017)
Table United States Serum (Blood) Sales (K Units) by Type (2012-2017)
Table United States Serum (Blood) Sales Share by Type (2012-2017)
Figure United States Serum (Blood) Sales Share by Type (2012-2017)
Figure United States Serum (Blood) Sales Market Share by Type in 2016
Table United States Serum (Blood) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Serum (Blood) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Serum (Blood) by Type (2012-2017)
Figure Revenue Market Share of Serum (Blood) by Type in 2016
Table United States Serum (Blood) Price (USD/Unit) by Types (2012-2017)
Figure United States Serum (Blood) Sales Growth Rate by Type (2012-2017)
Table United States Serum (Blood) Sales (K Units) by Application (2012-2017)
Table United States Serum (Blood) Sales Market Share by Application (2012-2017)
Figure United States Serum (Blood) Sales Market Share by Application (2012-2017)
Figure United States Serum (Blood) Sales Market Share by Application in 2016
Table United States Serum (Blood) Sales Growth Rate by Application (2012-2017)
Figure United States Serum (Blood) Sales Growth Rate by Application (2012-2017)
Table Thermo Fisher (Life-Tech) Basic Information List
Table Thermo Fisher (Life-Tech) Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher (Life-Tech) Serum (Blood) Sales Growth Rate (2012-2017)
Figure Thermo Fisher (Life-Tech) Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Thermo Fisher (Life-Tech) Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Sigma-Aldrich Basic Information List
Table Sigma-Aldrich Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sigma-Aldrich Serum (Blood) Sales Growth Rate (2012-2017)
Figure Sigma-Aldrich Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Sigma-Aldrich Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Serum (Blood) Sales Growth Rate (2012-2017)
Figure Merck Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Merck Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Corning Basic Information List
Table Corning Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Corning Serum (Blood) Sales Growth Rate (2012-2017)
Figure Corning Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Corning Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Bovogen Basic Information List
Table Bovogen Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bovogen Serum (Blood) Sales Growth Rate (2012-2017)
Figure Bovogen Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Bovogen Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Moregate Biotech Basic Information List
Table Moregate Biotech Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Moregate Biotech Serum (Blood) Sales Growth Rate (2012-2017)
Figure Moregate Biotech Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Moregate Biotech Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Biowest Basic Information List
Table Biowest Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biowest Serum (Blood) Sales Growth Rate (2012-2017)
Figure Biowest Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Biowest Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Gemini Basic Information List
Table Gemini Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gemini Serum (Blood) Sales Growth Rate (2012-2017)
Figure Gemini Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Gemini Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Bioind Basic Information List
Table Bioind Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bioind Serum (Blood) Sales Growth Rate (2012-2017)
Figure Bioind Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Bioind Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Tissue Culture Biologicals Basic Information List
Table Tissue Culture Biologicals Serum (Blood) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tissue Culture Biologicals Serum (Blood) Sales Growth Rate (2012-2017)
Figure Tissue Culture Biologicals Serum (Blood) Sales Market Share in United States (2012-2017)
Figure Tissue Culture Biologicals Serum (Blood) Revenue Market Share in United States (2012-2017)
Table Animal Technologies Basic Information List
Table South Pacific Sera Basic Information List
Table Lanzhou Minhai Basic Information List
Table Changchun Xinuo Basic Information List
Table Wuhan Sanli Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Serum (Blood)
Figure Manufacturing Process Analysis of Serum (Blood)
Figure Serum (Blood) Industrial Chain Analysis
Table Raw Materials Sources of Serum (Blood) Major Players/Suppliers in 2016
Table Major Buyers of Serum (Blood)
Table Distributors/Traders List
Figure United States Serum (Blood) Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Serum (Blood) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Serum (Blood) Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Serum (Blood) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Serum (Blood) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Serum (Blood) Sales Volume (K Units) Forecast by Type in 2022
Table United States Serum (Blood) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Serum (Blood) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Serum (Blood) Sales Volume (K Units) Forecast by Application in 2022
Table United States Serum (Blood) Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Serum (Blood) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Serum (Blood) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Serum (Blood) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources